1 Keys, A, Fidanza, F, Karvonen, MJ, et al. (1972) Indices of relative weight and obesity. J Chronic Dis 25, 329–343.
2 World Health Organization Committee on Obesity (2000) Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. Technical Report Series no. 894. Geneva: World Health Organization.
3 Inoue, S & Zimmet, P (2000) The Asia-Pacific Perspective: Redefining Obesity and its Treatment. Sydney: Health Communications Australia Pty Ltd.
4 World Health Organization Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363, 157–163.
5 World Health Organization Expert Committee on Physical Status (1995) Physical Status: The Use and Interpretation of Anthropometry. Technical Report Series no. 854. Geneva: World Health Organization.
6 Rush, EC, Freitas, I & Plank, LD (2009) Body size, body composition and fat distribution: comparative analysis of European, Maori, Pacific Island and Asian Indian adults. Br J Nutr 102, 632–641.
7 Deurenberg, P (2001) Universal cut-off BMI points for obesity are not appropriate. Br J Nutr 85, 135–136.
8 Craig, P, Colagiuri, S, Hussain, Z, et al. (2007) Identifying cut-points in anthropometric indexes for predicting previously undiagnosed diabetes and cardiovascular risk factors in the Tongan population. Obes Res Clin Pract 1, 17–25.
9 Gillett, MJ (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes: Diabetes Care 32(7): 1327–1334. Clin Biochem Rev 30, 197–200.
10 Kilpatrick, ES, Bloomgarden, ZT & Zimmet, PZ (2009) Is haemoglobin A1c a step forward for diagnosing diabetes? BMJ 339, b4432.
11 American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33, Suppl. 1, S62–S69.
12 Kilpatrick, ES (2008) Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J Clin Pathol 61, 977–982.
13 Rohlfing, CL, Little, RR, Wiedmeyer, HM, et al. (2000) Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 23, 187–191.
14 Ginde, AA, Cagliero, E, Nathan, DM, et al. (2008) Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population. J Gen Intern Med 23, 1346–1353.
15 Shemesh, T, Rowley, KG, Shephard, M, et al. (2006) Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities. Clin Chim Acta 367, 69–76.
16 Buchanan, JG, Jha, BK, Matthews, JR, et al. (1979) The prevalence and nature of anemia among apparently normal subjects in Fiji. Pathology 11, 369–376.
17 Zhang, X, Saaddine, JB, Chou, CF, et al. (2010) Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 304, 649–656.
18 Wen, CP, David Cheng, TY, Tsai, SP, et al. (2009) Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr 12, 497–506.
19 Razak, F, Anand, SS, Shannon, H, et al. (2007) Defining obesity cut points in a multiethnic population. Circulation 115, 2111–2118.
20 Nguyen, TT, Adair, LS, Suchindran, CM, et al. (2009) The association between body mass index and hypertension is different between East and Southeast Asians. Am J Clin Nutr 89, 1905–1912.
21 Odegaard, AO, Koh, WP, Vazquez, G, et al. (2009) BMI and diabetes risk in Singaporean Chinese. Diabetes Care 32, 1104–1106.
22 Misra, A, Chowbey, P, Makkar, BM, et al. (2009) Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India 57, 163–170.
24 Ko, GT, Chan, JC, Cockram, CS, et al. (1999) Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 23, 1136–1142.